Progranulin

Progranulin

Progranulin Overview

Molecule Name
Progranulin
Synonyms
CLN11, GEP, GP88, PCDGF, PEPI, PGRN
Drug Development Progress
Drugs in Clinical Trials7
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
GRN
Background
Progranulin, a secreted glycoprotein, is encoded in humans by the single GRN gene. Progranulin consists of seven and a half, tandemly repeated, non-identical copies of the 12 cysteine granulin motif. Many cellular processes and diseases are associated with this unique pleiotropic factor that include, but are not limited to, embryogenesis, tumorigenesis, inflammation, wound repair, neurodegeneration and lysosome function. Haploinsufficiency caused by autosomal dominant mutations within the GRN gene leads to frontotemporal lobar degeneration, a progressive neuronal atrophy that presents in patients as frontotemporal dementia.

Progranulin Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
GRN Gene Therapy(Eli Lilly And Company)PR-006; LY3884963Phase 2 ClinicalEli Lilly And Company
Frontotemporal Dementia
Details
TAK-594DNL-593; PTV:PGRN; TAK-594Phase 2 ClinicalDenali Therapeutics Inc
Frontotemporal Dementia
Details
AVB-101AVB-101Phase 2 ClinicalAviadoBio Ltd
Frontotemporal Dementia
Details
NivisnebartAL-101; GSK-4527226Phase 2 ClinicalAlector Inc
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Nerve Degeneration; Parkinson Disease
Details
PBFT-02PBFT-02Phase 2 ClinicalUniversity Of Pennsylvania
Frontotemporal Dementia
Details
VGN-R13VGN-R13Phase 1 ClinicalShanghai Vitalgen BioPharma Co Ltd
Amyotrophic Lateral Sclerosis
Details
AG-01(A&G Pharm)AG-01(A&G Pharm)Phase 1 ClinicalA&G Pharmaceutical
Carcinoma, Non-Small-Cell Lung; Mesothelioma; Triple Negative Breast Neoplasms
Details